Sensitivity and predictive value of criteria for p53 germline mutation

dicentric autosomes

[1]  D. Wallace,et al.  Immunocytochemical Characterization of the Mitochondrially Encoded ND1 Subunit of Complex I (NADH : Ubiquinone Oxidoreductase) in Rat Brain , 2000, Journal of neurochemistry.

[2]  P. Huygen,et al.  Familial progressive vestibulocochlear dysfunction caused by a COCH mutation (DFNA9). , 2000, Archives of neurology.

[3]  Yingze Zhang,et al.  Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C , 2000, Journal of medical genetics.

[4]  D. Rubinsztein,et al.  A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to chromosome 19q13. , 2000, American journal of human genetics.

[5]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[6]  J. Yokota,et al.  Familial gastric cancer: overview and guidelines for management* , 1999, Journal of medical genetics.

[7]  T. Sugai,et al.  Mitochondrial gene mutation, but not large‐scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability , 1999, International journal of cancer.

[8]  S. Pulst,et al.  Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation , 1999, Neurology.

[9]  Bertrand Fontaine,et al.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia , 1999, Nature Genetics.

[10]  D. Turnbull,et al.  Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.

[11]  D. Evans,et al.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. , 1999, American journal of human genetics.

[12]  D. Rubinsztein,et al.  Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular genetic study of 28 United Kingdom families. , 1999, Brain : a journal of neurology.

[13]  C. Cremers,et al.  Progressive Cochleovestibular Impairment Caused by a Point Mutation in the COCH Gene at DFNA9 , 1999, The Laryngoscope.

[14]  D. Rubinsztein,et al.  A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity. , 1999, American journal of human genetics.

[15]  C. Morton,et al.  High prevalence of symptoms of Menière's disease in three families with a mutation in the COCH gene. , 1999, Human molecular genetics.

[16]  C Eng,et al.  PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. , 1999, Human molecular genetics.

[17]  H. Höfler,et al.  Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. , 1999, The American journal of pathology.

[18]  S. Dimauro,et al.  Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNASer(UCN) gene , 1999, Neurology.

[19]  J. Yokota,et al.  Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. , 1999, Carcinogenesis.

[20]  C. Moraes,et al.  Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background. , 1999, Human molecular genetics.

[21]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[22]  J. Sedivy,et al.  Mysterious liaisons: the relationship between c-Myc and the cell cycle , 1999, Oncogene.

[23]  J. Ku,et al.  Germline mutations of E-cadherin gene in Korean familial gastric cancer patients , 1999, Journal of Human Genetics.

[24]  M. Lebwohl,et al.  Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN , 1999, Journal of medical genetics.

[25]  D. Turnbull,et al.  An mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalomyopathy. , 1999, American journal of human genetics.

[26]  L. Sudarsky,et al.  Dystonia as a presenting feature of the 3243 mitochondrial DNA mutation , 1999, Movement disorders : official journal of the Movement Disorder Society.

[27]  D. Evans,et al.  Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. , 1999, Human molecular genetics.

[28]  N. Tommerup,et al.  Systematic characterisation of disease associated balanced chromosome rearrangements by FISH: cytogenetically and genetically anchored YACs identify microdeletions and candidate regions for mental retardation genes , 1999, Journal of medical genetics.

[29]  C. Cremers,et al.  A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. , 1999, Human molecular genetics.

[30]  M. Leppert,et al.  Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q. , 1999, American journal of human genetics.

[31]  I. D. de Coo,et al.  A 4–base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome , 1999, Annals of neurology.

[32]  J. Gosálvez,et al.  Evidence of a differential organization of chromatin containing terminal or interstitial (TTAGGG)n repeats by in situ digestion with nucleases , 1998, Cytogenetic and Genome Research.

[33]  C. Eng,et al.  Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. , 1998, American journal of medical genetics.

[34]  M. Meisler,et al.  Exon organization, coding sequence, physical mapping, and polymorphic intragenic markers for the human neuronal sodium channel gene SCN8A. , 1998, Genomics.

[35]  C. Eng,et al.  Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype. , 1998, Journal of medical genetics.

[36]  Bert Vogelstein,et al.  Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.

[37]  R. Eeles,et al.  Germline PTEN mutations in Cowden syndrome-like families. , 1998, Journal of medical genetics.

[38]  H. Willard,et al.  Stable dicentric X chromosomes with two functional centromeres , 1998, Nature Genetics.

[39]  J. Diliberti Inherited macrocephaly-hamartoma syndromes. , 1998, American journal of medical genetics.

[40]  Kylie L. Gorringe,et al.  Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. , 1998, Cancer research.

[41]  P. Marynen,et al.  Prader-Willi syndrome. , 1998, The American journal of psychiatry.

[42]  S. Tabrizi,et al.  The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy , 1998, Annals of neurology.

[43]  S. Tabrizi,et al.  Mitochondrial DNA in focal dystonia: A cybrid analysis , 1998, Annals of neurology.

[44]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[45]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[46]  D. Saranath,et al.  Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India. , 1998, Cancer letters.

[47]  C Eng,et al.  Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. , 1998, Human molecular genetics.

[48]  Hanlee P. Ji,et al.  Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. , 1997, American journal of human genetics.

[49]  J. Ott,et al.  The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. , 1997, American journal of human genetics.

[50]  D. Broccoli,et al.  Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2 , 1997, Nature Genetics.

[51]  R. Zori,et al.  Fluorescence in situ hybridization assessment of the telomeric regions of jumping translocations in a case of aggressive B-cell non-Hodgkin lymphoma. , 1997, Cancer genetics and cytogenetics.

[52]  J. Arenas,et al.  Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene. , 1997, Biochemical and biophysical research communications.

[53]  B. Ulm,et al.  Dandy–Walker malformation diagnosed before 21 weeks of gestation: associated malformations and chromosomal abnormalities , 1997, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[54]  M. Nelen,et al.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. , 1997, Human molecular genetics.

[55]  D. Evans,et al.  Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. , 1997, Cancer research.

[56]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[57]  P. Marynen,et al.  Interstitial telomeric sequences at the junction site of a jumping translocation , 1997, Human Genetics.

[58]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[59]  N. Leboucq,et al.  Familial Dandy-Walker malformation and leukodystrophy. , 1997, Pediatric neurology.

[60]  A. Schapira,et al.  Complex I function in familial and sporadic dystonia , 1997, Annals of neurology.

[61]  Miguel A. Preciado,et al.  Down syndrome: characterisation of a case with partial trisomy of chromosome 21 owing to a paternal balanced translocation (15;21) (q26;q22.1) by FISH. , 1997, Journal of medical genetics.

[62]  S. Bouffler Involvement of telomeric sequences in chromosomal aberrations. , 1996, Mutation research.

[63]  S. Orlow,et al.  Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. , 1996, Archives of dermatology.

[64]  K. Calame,et al.  YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Seidman,et al.  A gene for non-syndromic autosomal dominant progressive postlingual sensorineural hearing loss maps to chromosome 14q12-13. , 1996, Human molecular genetics.

[66]  J. D. Porter,et al.  The Neuronal Voltage-Gated Sodium Channel, Scn8a, Is Essential for Postnatal Maturation of Spinal, but Not Oculomotor, Motor Units , 1996, Experimental Neurology.

[67]  G. Bruyn,et al.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. , 1996, American journal of human genetics.

[68]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[69]  D. Wallace,et al.  Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia , 1996, Molecular and cellular biology.

[70]  B. Robinson,et al.  Familial Cardiomyopathy with Cataracts and Lactic Acidosis: A Defect in Complex I (NADH-Dehydrogenase) of the Mitochondria Respiratory Chain , 1996, Pediatric Research.

[71]  G. Thomas,et al.  Incidence of germ‐line p53 mutations in patients with gliomas , 1995, International journal of cancer.

[72]  J. Biegel,et al.  p53 gene mutations in pediatric brain tumors. , 1995, Medical and pediatric oncology.

[73]  M. Vijver,et al.  E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.

[74]  D. Evans,et al.  An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. , 1995, Journal of medical genetics.

[75]  L. Sandkuijl,et al.  Perspectives of identity by descent (IBD) mapping in founder populations , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[76]  R. A. Petersen,et al.  Bilateral infantile cataractogenesis in a patient with deficiency of complex I, a mitochondrial electron transport chain enzyme. , 1995, Journal of pediatric ophthalmology and strabismus.

[77]  M. Meisler,et al.  Mutation of a new sodium channel gene, Scn8a, in the mouse mutant ‘motor endplate disease’ , 1995, Nature Genetics.

[78]  D. Wallace,et al.  Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation , 1995, Annals of neurology.

[79]  K. Huoponen,et al.  Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[80]  M. Prados,et al.  Constitutional p53 mutations associated with brain tumors in young adults. , 1995, Cancer genetics and cytogenetics.

[81]  P. Yarowsky,et al.  A novel, abundant sodium channel expressed in neurons and glia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[82]  P. Chappuis,et al.  A simple p53 functional assay for screening cell lines, blood, and tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Gottlieb,et al.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. , 1995, The Journal of clinical investigation.

[84]  S. Friend,et al.  Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. , 1995, American journal of human genetics.

[85]  J. Flint,et al.  The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation , 1995, Nature Genetics.

[86]  D. Lane,et al.  Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. , 1994, British Journal of Cancer.

[87]  J. Fraumeni,et al.  Collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[88]  C. Portwine,et al.  High frequency of germline p53 mutations in childhood adrenocortical cancer. , 1994, Journal of the National Cancer Institute.

[89]  M. Pericak-Vance,et al.  Linkage of a locus for autosomal dominant familial spastic paraplegia to chromosome 2p markers. , 1994, Human molecular genetics.

[90]  Liang Zhu,et al.  Interaction of c‐Myc with the pRb‐related protein p107 results in inhibition of c‐Myc‐mediated transactivation. , 1994, The EMBO journal.

[91]  Y. Agid,et al.  Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. , 1994, Human molecular genetics.

[92]  F. Bieber,et al.  Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. , 1994, Genomics.

[93]  G. Gaidano,et al.  Mutations in the Coding Region of c-myc Occur Frequently in Acquired Immunodeficiency Syndrome-Associated Lymphomas , 1994 .

[94]  M. Raffeld,et al.  Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. , 1994, Cancer research.

[95]  R. Stevenson,et al.  X–linked spastic paraplegia (SPG1), MASA syndrome and X–linked hydrocephalus result from mutations in the L1 gene , 1994, Nature Genetics.

[96]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Mott,et al.  An integrated YAC-overlap and 'cosmid-pocket' map of the human chromosome 21. , 1994, Human molecular genetics.

[98]  C. Dang,et al.  Binding and suppression of the Myc transcriptional activation domain by p107. , 1994, Science.

[99]  M. Morrison,et al.  Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma. , 1994, British Journal of Cancer.

[100]  A. Craft,et al.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. , 1994, Cancer research.

[101]  A. Munnich,et al.  X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus , 1994, Nature Genetics.

[102]  S. Goff,et al.  Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. , 1993, Science.

[103]  J. Fryns,et al.  Cowden syndrome: report of a large family with macrocephaly and increased severity of signs in subsequent generations , 1993, Clinical genetics.

[104]  K. Calame,et al.  Yin-yang 1 activates the c-myc promoter , 1993, Molecular and cellular biology.

[105]  G. Floridia,et al.  Types, stability, and phenotypic consequences of chromosome rearrangements leading to interstitial telomeric sequences. , 1993, Journal of medical genetics.

[106]  S. Friend,et al.  Screening patients for heterozygous p53 mutations using a functional assay in yeast , 1993, Nature genetics.

[107]  M. Raffeld,et al.  Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. , 1993, Oncogene.

[108]  J. Weissenbach,et al.  Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q , 1993, Nature genetics.

[109]  J. Yokota,et al.  Germ-line p53 mutation is uncommon in patients with triple primary cancers. , 1993, Cancer letters.

[110]  I. Magrath,et al.  Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas , 1993, Nature Genetics.

[111]  G. Thomas,et al.  Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. , 1993, Oncogene.

[112]  Fangnian Wang,et al.  A new stable human dicentric chromosome, tdic(4;21)(p16;q22), in a woman with first trimester abortion. , 1993, Journal of medical genetics.

[113]  A. Polack,et al.  Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift. , 1993, Oncogene.

[114]  P. H. Jones,et al.  Wilms' tumor in the Li-Fraumeni cancer family syndrome. , 1993, Cancer genetics and cytogenetics.

[115]  R. Burke,et al.  Disorders of Movement in Leigh Syndrome , 1993, Neuropediatrics.

[116]  C. Bonaïti‐pellié,et al.  Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. , 1993, Cancer research.

[117]  J. Walker,et al.  Conservation of sequences of subunits of mitochondrial complex I and their relationships with other proteins. , 1992, Biochimica et biophysica acta.

[118]  S. Holden,et al.  A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. , 1992, The Journal of bone and joint surgery. British volume.

[119]  R. Benecke,et al.  Electron transfer complex I defect in idiopathic dystonia , 1992, Annals of neurology.

[120]  W. Bles,et al.  A new autosomal dominant syndrome of idiopathic progressive vestibulo-cochlear dysfunction with middle-age onset. , 1992, Acta oto-laryngologica.

[121]  X. Estivill,et al.  Continuum of overlapping clones spanning the entire human chromosome 21q , 1992, Nature.

[122]  S. Friend,et al.  Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. , 1992, Journal of the National Cancer Institute.

[123]  S. Friend,et al.  Screening for germ line TP53 mutations in breast cancer patients. , 1992, Cancer research.

[124]  R. Ohi,et al.  Bannayan-Zonana syndrome associated with lipomas, hemangiomas, and lymphangiomas. , 1992, Journal of pediatric surgery.

[125]  B. Vogelstein,et al.  Inherited p53 gene mutations in breast cancer. , 1992, Cancer research.

[126]  R. Weichselbaum,et al.  Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. , 1992, The New England journal of medicine.

[127]  S. Friend,et al.  Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. , 1992, The New England journal of medicine.

[128]  F. Collins,et al.  An optimized Alu-PCR primer pair for human-specific amplification of YACs and somatic cell hybrids. , 1992, Human molecular genetics.

[129]  V. Park,et al.  The presence of interstitial telomeric sequences in constitutional chromosome abnormalities. , 1992, American journal of human genetics.

[130]  H. J. Evans,et al.  Constitutional p53 mutation in a non-Li-Fraumeni cancer family. , 1992, British Journal of Cancer.

[131]  J. Fraumeni,et al.  Follow-up study of twenty-four families with Li-Fraumeni syndrome. , 1991, Cancer research.

[132]  J. Fraumeni,et al.  Testing for germ line p53 mutations in cancer families. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[133]  S. Ben-Neriah,et al.  "Jumping translocation" in a 17-month-old child with mixed-lineage leukemia. , 1991, Cancer genetics and cytogenetics.

[134]  N. E. MORTON,et al.  Genetic Epidemiology of Hearing Impairment , 1991, Annals of the New York Academy of Sciences.

[135]  R. Martuza,et al.  TP53 Gene Mutations and 17p Deletions in Human Astrocytomas , 1991, Genes, chromosomes & cancer.

[136]  E. Courchesne,et al.  Protocols to establish genotype-phenotype correlations in Down syndrome. , 1991, American journal of human genetics.

[137]  I. Dubé,et al.  "Jumping" translocations involving band 3q13.3 in a case of acute monocytic leukemia. , 1991, Cancer genetics and cytogenetics.

[138]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[139]  D. Moretti-Ferreira,et al.  Macrocephaly, multiple lipomas, and hemangiomata (Bannayan-Zonana syndrome): genetic heterogeneity or autosomal dominant locus with at least two different allelic forms? , 1989, American journal of medical genetics.

[140]  O. Zuffardi,et al.  Alternate centromere inactivation in a pseudodicentric (15;20)(pter;pter) associated with a progressive neurological disorder. , 1989, Journal of medical genetics.

[141]  D. J. Driscoll,et al.  Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. , 1989, Genomics.

[142]  E. Joosten,et al.  Hereditary vestibulo-cochlear dysfunction and vascular disorders , 1989, Journal of the Neurological Sciences.

[143]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[144]  E. Joosten,et al.  Familial progressive vestibulocochlear dysfunction. , 1988, Archives of neurology.

[145]  L. Strong,et al.  Cancer in survivors of childhood soft tissue sarcoma and their relatives. , 1987, Journal of the National Cancer Institute.

[146]  H. B. Marsden,et al.  Malignant melanoma in families of children with osteosarcoma, chondrosarcoma, and adrenal cortical carcinoma. , 1987, Journal of medical genetics.

[147]  D. Eick,et al.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. , 1986, Nucleic acids research.

[148]  K. Marcu,et al.  Intragenic pausing and anti‐sense transcription within the murine c‐myc locus. , 1986, The EMBO journal.

[149]  R. Zinkowski,et al.  Sequence of centromere separation: a mechanism for orderly separation of dicentrics. , 1986, Cancer genetics and cytogenetics.

[150]  Mark Groudine,et al.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.

[151]  F. Arwert,et al.  The Cowden syndrome: a clinical and genetic study in 21 patients , 1986, Clinical genetics.

[152]  P. Howard,et al.  Familial transmission of a non‐Robertsonian translocation dicentric , 1986, Clinical genetics.

[153]  M. Kida,et al.  A complex mosaic with tdic(13;18) (p11;p11), +13p-, +18p-, r(13) etc. in a male infant , 1986, Japanese Journal of Human Genetics.

[154]  J. Opitz,et al.  NOR activity and centromere suppression related in a de novo fusion tdic(9;13)(p22;p13) chromosome in a child with del(9p) syndrome. , 1985, American journal of medical genetics.

[155]  J. Zonana,et al.  Macrocephaly with hamartomas: Bannayan-Zonana syndrome. , 1984, American journal of medical genetics.

[156]  F. Sarkar,et al.  Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[157]  H. B. Marsden,et al.  Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. , 1984, British Journal of Cancer.

[158]  D. F. Roberts,et al.  Two families with the Li-Fraumeni cancer family syndrome , 1982, Journal of medical genetics.

[159]  R. Stevenson,et al.  Mental retardation in the Bannayan syndrome. , 1982, Pediatrics.

[160]  P. Schultz,et al.  The Bannayan syndrome: an autosomal dominant disorder consisting of macrocephaly, lipomas, hemangiomas, and risk for intracranial tumors. , 1982, Pediatrics.

[161]  R. Ruvalcaba,et al.  Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia , 1980, Clinical genetics.

[162]  A. Clarke,et al.  Familial dicentric translocation t(13;18)(p13;p11.2) ascertained by recurrent miscarriages. , 1979, Journal of medical genetics.

[163]  A. Serra,et al.  A complex mosaic with D/E translocation tdic(15;18) (p12;p11) in an oligospermic male with apparently total infertility , 1977, Clinical genetics.

[164]  R. Howell,et al.  Stable dicentric autosome, tdic (8:22)(p23:p13), in a mentally retarded girl. , 1977, Journal of medical genetics.

[165]  D. Rimoin,et al.  Macrocephaly with multiple lipomas and hemangiomas. , 1976, The Journal of pediatrics.

[166]  Y. Nakagome,et al.  Mental retardation, malformation syndrome and partial 7p monosomy [45, XX, tdic (7;15) (p21;pll)] , 1976, Clinical genetics.

[167]  J. Jackson,et al.  Clinical diagnosis of Down's syndrome , 1976, Clinical genetics.

[168]  G. Myers,et al.  Benign familial macrocephaly: report of a family and review of the literature. , 1976, Pediatrics.

[169]  W. Behan,et al.  Strümpell's familial spastic paraplegia: genetics and neuropathology , 1974, Journal of neurology, neurosurgery, and psychiatry.

[170]  A. Henderson,et al.  A stable human dicentric chromosome, t dic (12;14)(p13;p13) including an intercalary satellite region between centromeres. , 1973, American journal of human genetics.

[171]  V. Michels The Genetic Basis of Human Cancer , 1999 .

[172]  D. Simon,et al.  Mitochondrial disorders: clinical and genetic features. , 1999, Annual review of medicine.

[173]  S. Markowitz,et al.  E‐cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer , 1999, Human mutation.

[174]  A. Munnich,et al.  Macular dystrophy, diabetes, and deafness associated with a large mitochondrial DNA deletion. , 1998, American journal of ophthalmology.

[175]  Heinz Höfler,et al.  Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.

[176]  D. Evans,et al.  Li-Fraumeni syndrome--a molecular and clinical review. , 1997, British Journal of Cancer.

[177]  A. Patel,et al.  Differential regulation of the c-MYC P1 and P2 promoters in the absence of functional tumor suppressors: implications for mechanisms of deregulated MYC transcription. , 1997, Current topics in microbiology and immunology.

[178]  H. Wanamaker,et al.  Hereditary hearing loss and its syndromes , 1996 .

[179]  L. Coignet,et al.  FISH and PRINS, a strategy for rapid chromosome screening: application to the assessment of aneuploidy in human sperm. , 1996, Cytogenetics and cell genetics.

[180]  M. Tsuda [Chromosomal abnormalities]. , 1995, Ryoikibetsu shokogun shirizu.

[181]  R. Eeles Germline mutations in the TP53 gene. , 1995, Cancer surveys.

[182]  B. Otterud,et al.  Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. , 1995, American journal of human genetics.

[183]  H. Cooke 8 Non-programmed and Engineered Chromosome Breakage , 1995 .

[184]  C. Marsden,et al.  Dystonia as the major manifestation of Leigh's syndrome , 1994, Movement disorders : official journal of the Movement Disorder Society.

[185]  G. Gaidano,et al.  Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. , 1994, Blood.

[186]  S. Friend,et al.  Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. , 1994, Medical and pediatric oncology.

[187]  W. Verhagen,et al.  Peripheral vestibular and vestibulo-cochlear dysfunction in hereditary disorders. A review of the literature and a report on some additional findings. , 1994, Journal of vestibular research : equilibrium & orientation.

[188]  F. Hosoda,et al.  A NotI restriction map of the entire long arm of human chromosome 21. , 1993, Nature genetics.

[189]  R. Eeles Predictive testing for germline mutations in the p53 gene: are all the questions answered? , 1993, European journal of cancer.

[190]  P. Meltzer,et al.  Telomere capture stabilizes chromosome breakage , 1993, Nature Genetics.

[191]  J. Delabar,et al.  Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21 , 1993, European journal of human genetics : EJHG.

[192]  S. Friend,et al.  Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma , 1992 .

[193]  B. Ponder,et al.  No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families. , 1992, Oncogene.

[194]  M. K. McCormick Molecular genetic approach to the characterization of the ‘Down syndrome region’ of chromosome 21 , 1989 .

[195]  T. Graf,et al.  The transforming activity of the chicken c-myc gene can be potentiated by mutations. , 1987, Oncogene.

[196]  C. Rosenberg,et al.  Deletion of the centromere as a mechanism for achieving stability of a dicentric chromosome. , 1986, Cytogenetics and cell genetics.

[197]  P. Jacobs,et al.  Trisomy in man. , 1984, Annual review of genetics.

[198]  K. Sit,et al.  Translocation dicentric chromosomes in prostaglandin E2 induced abortuses and possible aneusomy through asynchronous centromeric divisions. , 1981, Cytogenetics and cell genetics.

[199]  G. Dewald,et al.  A tdic(5;15)(p31;p11) chromosome showing variation for constriction in the centromeric regions in a patient with the cri du chat syndrome. , 1979, Cytogenetics and cell genetics.

[200]  G. Sekhon,et al.  Identification of a 19/20 translocation by G-, Q- and C-banding. , 1975, Birth defects original article series.

[201]  E. Niebuhr A 45,XX,5-,13-,dic+ karyotype in a case of cri-du-chat syndrome. , 1972, Cytogenetics.

[202]  B Dutrillaux,et al.  Sur une nouvelle technique d'analyse du caryotype humain. , 1971 .

[203]  M. E. VARELA,et al.  Human Chromosomes , 1945, Nature.